Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, pursuant to the Answer to Question 224953 of 2 March 2015, whether Duodopa was considered for funding by NHS England for routine funding in the 2013-14 financial year.

NHS England has advised that the draft clinical policy for recommending the funding of Duodopa was presented and considered in 2014-15. Before this time, the commissioning responsibility for Duodopa rested with clinical commissioning groups.